Neoprospecta Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 66


  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

Neoprospecta General Information


Developer of a biotechnology platform intended to help researchers deal with microbiological analysis, management and control. The company's platform offers biocomputational analysis and quantitative PCR techniques which have created a line of rapid tests for the detection of microorganisms and antibiotic-resistance genes, enabling medical researchers to identify microorganisms using DNA sequencing technologies.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Media and Information Services (B2B)
Corporate Office
  • Avenida Luiz Boiteux Piazza
  • 1302 - Canasvieiras Sapiens Parque
  • Florianopolis, 88054
  • Brazil
+55 (48) 0000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoprospecta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 01-Jun-2016 00.000 Completed Generating Revenue
2. Early Stage VC 08-Aug-2014 00.000 00.000 Completed Generating Revenue
1. Early Stage VC 15-Feb-2013 $249K $249K Completed Generating Revenue
To view Neoprospecta’s complete valuation and funding history, request access »

Neoprospecta Patents

Neoprospecta Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160273031-A1 Method, kit and premix for quantitative and discriminative determination of nucleic acids, qdpcr; in vitro method for the quantitative and discriminative diagnosis of biological entities Inactive 18-Nov-2013 0000000000

Neoprospecta Executive Team (5)

Name Title Board Seat Contact Info
Luiz Fernando Oliveira Founding Partner & Chief Executive Officer
Pedro Stadnik Controller
Luiz Felipe Valter de Oliveira Ph.D Co-Founder & Board Member
Ronaldo Mota Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Neoprospecta Board Members (1)

Name Representing Role Since
Luiz Felipe Valter de Oliveira Ph.D Neoprospecta Co-Founder & Board Member 000 0000
To view Neoprospecta’s complete board members history, request access »

Neoprospecta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neoprospecta Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CRP Companhia de Participacoes Venture Capital Minority 000 0000 000000 0
CVentures Corporate Venture Capital Minority 000 0000 000000 0
Felipe Marcondes de Mattos Angel (individual) Minority 000 0000 000000 0
Spectra Investments PE/Buyout Minority 000 0000 000000 0
IDEE (Other Commercial Products) Venture Capital Minority 000 0000 000000 0
To view Neoprospecta’s complete investors history, request access »

Neoprospecta FAQs

  • When was Neoprospecta founded?

    Neoprospecta was founded in 2011.

  • Who is the founder of Neoprospecta?

    Marcos Oliveira de Carvalho, Luiz Felipe Valter de Oliveira Ph.D, and Ronaldo Mota are the founders of Neoprospecta.

  • Who is the CEO of Neoprospecta?

    Luiz Fernando Oliveira is the CEO of Neoprospecta.

  • Where is Neoprospecta headquartered?

    Neoprospecta is headquartered in Florianopolis, Brazil.

  • What is the size of Neoprospecta?

    Neoprospecta has 66 total employees.

  • What industry is Neoprospecta in?

    Neoprospecta’s primary industry is Biotechnology.

  • Is Neoprospecta a private or public company?

    Neoprospecta is a Private company.

  • What is Neoprospecta’s current revenue?

    The current revenue for Neoprospecta is 000000.

  • How much funding has Neoprospecta raised over time?

    Neoprospecta has raised $2.03M.

  • Who are Neoprospecta’s investors?

    CRP Companhia de Participacoes, CVentures, Felipe Marcondes de Mattos, Spectra Investments, and IDEE (Other Commercial Products) have invested in Neoprospecta.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »